Opinion
Video
A medical professional examines the pivotal roles of molecular profiling, next-generation sequencing, and germline testing in guiding treatment decisions for ovarian cancer.
Advances in Ovarian Cancer: Using Genomics and Optimizing Maintenance Therapy
Five Years Later: Ongoing COVID-19 Challenges, Next Steps
Lower Risk of Cardiovascular Events With Acalabrutinib vs Ibrutinib in CLL in Real-World Study
Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi
Access to Minimally Invasive Surgery for Advanced Ovarian Cancer Varies Widely by Facility
Retifanlimab Becomes First FDA-Approved Frontline Treatment for Advanced Anal Cancer